JP2011505414A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011505414A5 JP2011505414A5 JP2010536523A JP2010536523A JP2011505414A5 JP 2011505414 A5 JP2011505414 A5 JP 2011505414A5 JP 2010536523 A JP2010536523 A JP 2010536523A JP 2010536523 A JP2010536523 A JP 2010536523A JP 2011505414 A5 JP2011505414 A5 JP 2011505414A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- composition
- subject
- item
- factor viii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0723712.6A GB0723712D0 (en) | 2007-12-04 | 2007-12-04 | Peptides |
| GB0723712.6 | 2007-12-04 | ||
| PCT/GB2008/003996 WO2009071886A1 (en) | 2007-12-04 | 2008-12-03 | Fviii peptides and their use in tolerising haemophiliacs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014023217A Division JP6063402B2 (ja) | 2007-12-04 | 2014-02-10 | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011505414A JP2011505414A (ja) | 2011-02-24 |
| JP2011505414A5 true JP2011505414A5 (cg-RX-API-DMAC7.html) | 2012-10-25 |
| JP5501245B2 JP5501245B2 (ja) | 2014-05-21 |
Family
ID=38982965
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010536523A Expired - Fee Related JP5501245B2 (ja) | 2007-12-04 | 2008-12-03 | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 |
| JP2014023217A Expired - Fee Related JP6063402B2 (ja) | 2007-12-04 | 2014-02-10 | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014023217A Expired - Fee Related JP6063402B2 (ja) | 2007-12-04 | 2014-02-10 | Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用 |
Country Status (25)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2353347T3 (es) | 2000-08-21 | 2011-03-01 | Apitope Technology (Bristol) Limited | Péptido. |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
| SI2300497T1 (sl) * | 2008-06-24 | 2013-02-28 | Octapharma Ag | Postopek za äťiĺˇäťenje koagulacijskega faktorja viii |
| GB0908515D0 (en) * | 2009-05-18 | 2009-06-24 | Apitope Technology Bristol Ltd | Peptide |
| CA2765657A1 (en) * | 2009-06-16 | 2010-12-23 | Tokai University | Anti-gram-negative bacteria agent |
| CN104926947A (zh) | 2010-10-27 | 2015-09-23 | 巴克斯特国际公司 | 用于免疫耐受性诱导和免疫诊断的fviii肽 |
| CA2863329C (en) | 2012-01-12 | 2023-01-03 | Biogen Idec Ma Inc. | Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy |
| EA036483B1 (ru) * | 2012-11-12 | 2020-11-16 | Эпитоп Интернэшнл Нв | Пептиды, способные индуцировать толерантность к рекомбинантному fviii, содержащая их композиция, их применение и способ лечения гемофилии |
| GB201314052D0 (en) | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| CA3007262A1 (en) | 2015-12-03 | 2017-06-08 | Lucas James Thompson | Modified chimeric receptors and related compositions and methods |
| KR20190091292A (ko) | 2016-12-02 | 2019-08-05 | 바이오버라티브 테라퓨틱스 인크. | 응고 인자에 대한 면역 내성 유도 방법 |
| US12077607B2 (en) * | 2021-09-23 | 2024-09-03 | University Of Utah Research Foundation | Functional and therapeutic effects of PAR4 cleavage by cathepsin G |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5930890A (en) * | 1989-06-20 | 1991-01-08 | Scripps Clinic And Research Foundation | The phospholipid binding domain of factor viii |
| BR9806793A (pt) * | 1997-01-22 | 2000-05-16 | Univ Texas | Processos e composições de fator tissular para coagulação e tratamento de tumores. |
| ES2353347T3 (es) * | 2000-08-21 | 2011-03-01 | Apitope Technology (Bristol) Limited | Péptido. |
| WO2002060917A2 (en) * | 2000-12-01 | 2002-08-08 | Regents Of The University Of Minnesota | Method to treat hemophilia |
| HUP0303171A2 (hu) * | 2001-02-19 | 2003-12-29 | Merck Patent Gmbh | Csökkentett immunogenitású mesterséges fehérjék |
| AU2002312660A1 (en) * | 2001-05-31 | 2002-12-16 | D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| AU2003232482A1 (en) * | 2002-04-18 | 2003-10-27 | Merck Patent Gmbh | Modified factor viii |
| AU2005211725B2 (en) * | 2004-02-09 | 2010-07-15 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| WO2006003183A1 (de) | 2004-07-02 | 2006-01-12 | Alois Jungbauer | Peptide zur blockierung von fviii-inhibitoren |
| IL229645A0 (en) * | 2013-11-26 | 2014-03-31 | Omrix Biopharmaceuticals Ltd | A dry bandage containing thrombin and pectin |
-
2007
- 2007-12-04 GB GBGB0723712.6A patent/GB0723712D0/en not_active Ceased
-
2008
- 2008-03-12 UA UAA201008194A patent/UA101003C2/uk unknown
- 2008-12-03 US US12/746,141 patent/US8445448B2/en not_active Expired - Fee Related
- 2008-12-03 CN CN201310392152.6A patent/CN103709234B/zh not_active Expired - Fee Related
- 2008-12-03 SI SI200831186T patent/SI2227488T1/sl unknown
- 2008-12-03 ES ES08855772.3T patent/ES2458315T7/es active Active
- 2008-12-03 AU AU2008332968A patent/AU2008332968B2/en not_active Ceased
- 2008-12-03 JP JP2010536523A patent/JP5501245B2/ja not_active Expired - Fee Related
- 2008-12-03 HR HRP20140344TT patent/HRP20140344T4/hr unknown
- 2008-12-03 PL PL08855772T patent/PL2227488T6/pl unknown
- 2008-12-03 CA CA2707559A patent/CA2707559C/en active Active
- 2008-12-03 CN CN200880119313.1A patent/CN101889024B/zh not_active Expired - Fee Related
- 2008-12-03 MY MYPI20102567 patent/MY150995A/en unknown
- 2008-12-03 PT PT88557723T patent/PT2227488E/pt unknown
- 2008-12-03 WO PCT/GB2008/003996 patent/WO2009071886A1/en not_active Ceased
- 2008-12-03 EP EP08855772.3A patent/EP2227488B3/en active Active
- 2008-12-03 KR KR1020107011743A patent/KR101519840B1/ko not_active Expired - Fee Related
- 2008-12-03 NZ NZ585217A patent/NZ585217A/xx not_active IP Right Cessation
- 2008-12-03 BR BRPI0820143 patent/BRPI0820143A2/pt not_active Application Discontinuation
- 2008-12-03 EA EA201070681A patent/EA019370B1/ru not_active IP Right Cessation
- 2008-12-03 MX MX2010006084A patent/MX2010006084A/es active IP Right Grant
- 2008-12-03 DK DK08855772.3T patent/DK2227488T6/en active
- 2008-12-03 CA CA3005013A patent/CA3005013C/en active Active
-
2010
- 2010-04-29 ZA ZA2010/02997A patent/ZA201002997B/en unknown
- 2010-05-13 IL IL205780A patent/IL205780A/en active IP Right Grant
- 2010-07-02 EC EC2010010327A patent/ECSP10010327A/es unknown
-
2014
- 2014-02-10 JP JP2014023217A patent/JP6063402B2/ja not_active Expired - Fee Related
- 2014-04-15 CY CY20141100281T patent/CY1115168T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011505414A5 (cg-RX-API-DMAC7.html) | ||
| Lhuillier et al. | Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control | |
| Marasca et al. | LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion | |
| Paunovska et al. | Using large datasets to understand nanotechnology | |
| Morató et al. | Symptomatic and disease-modifying therapy pipeline for Alzheimer’s disease: Towards a personalized polypharmacology patient-centered approach | |
| US20170312334A1 (en) | Methods and compositions for treating inflammatory disorders | |
| Zhang et al. | Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients | |
| EA200802242A1 (ru) | Способ определения того, будет или не будет пациент респондером на иммунотерапию | |
| JP2008508859A5 (cg-RX-API-DMAC7.html) | ||
| MY161844A (en) | Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
| Stone et al. | Genomics of human fibrotic diseases: disordered wound healing response | |
| CN112679604A (zh) | 用于肺癌(包括非小细胞肺癌和其他癌症)免疫治疗的新型肽和肽组合物 | |
| Mirizio et al. | Genetic signatures from RNA sequencing of pediatric localized scleroderma skin | |
| TWI733719B (zh) | 改善的組合物及用於新表位之病毒遞送的方法及其應用 | |
| UA116194C2 (uk) | Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном | |
| JP2014533102A5 (cg-RX-API-DMAC7.html) | ||
| JP2017524348A5 (cg-RX-API-DMAC7.html) | ||
| NO20092522L (no) | Sammensetninger og fremgangsmater for a behandle kreft med cupredoxiner og CPG rikt DNA | |
| Mitsui et al. | Molecular mechanisms and risk factors related to the pathogenesis of Peyronie’s disease | |
| JP2009540852A5 (cg-RX-API-DMAC7.html) | ||
| Tessier et al. | Exploration of nuclear body-enhanced sumoylation reveals that PML represses 2-cell features of embryonic stem cells | |
| WO2018200489A1 (en) | Il-8, il-6, il-1b and tet2 and dnmt3a in atherosclerosis | |
| Kjer-Hansen et al. | Protein isoform-centric therapeutics: expanding targets and increasing specificity | |
| Turcot et al. | Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. |